Back to Top
Anti-Human CD19 (FMC63) Antibody
Anti-FMC63 (IB11) Antibody
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE and HPLC
Species Reactivity
Human
Target
FMC63
Concentration
1.0 - 5.0 mg/ml
Isotype
Human IgG1 Kappa
Host
CHO Cells
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes
This antibody is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Storage
Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½20°C or -80°C. Avoid Repeated Freeze Thaw Cycles.
Formulation
Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity
FMC63
Shipping Conditions
Blue ice
Background
The FMC63 binder is the prototypical CD19-targeting domain underpinning much CAR research, and antibodies that recognise FMC63-based constructs are valuable tools for detecting and validating engineered receptors. Clone IB11 is a human IgG1 kappa antibody that recognises the FMC63 idiotype. Anti-FMC63 IB11 is supplied in a low-endotoxin format suitable for in vivo use and manufactured in scalable milligram to gram quantities for bulk and high-throughput laboratories. As a research-use-only, non-therapeutic reagent, clone IB11 provides reproducible, lot-consistent performance for CAR detection, anti-idiotype, and cell-therapy research workflows.
Clone
IB11
Buffer
ICH3002
Write Your Own Review

















